Labshake search
Citations for Tocris :
401 - 450 of 1235 citations for 6 aminonaphthalene 1 3 disulphonic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2021Quote: ... cells were pre-treated for 6 hours with 100 μM CPYPP (DOCK-i; No4568, Tocris). To inhibit Shh signaling ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 µM 6-cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris Bioscience, Briston, UK) and 50 µM D-(-)-2-amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Neuroscience 2022Quote: ... 6-N,N-Diethyl-β-γ-dibromomethylene-D-adenosine-5′-triphosphate (ARL 67156; Tocris, 1283) was perfused through the probe at concentrations of 1 mM ...
-
bioRxiv - Immunology 2023Quote: ... coated 6 cm dishes in mTeSR Plus media with 10 μM Y-27632 (Tocris, 1254). On Day 0 ...
-
bioRxiv - Neuroscience 2023Quote: ... P3029) and 2-methyl-6-(phenylethynyl)pyridine (MPEP; Tocris, Ellisville, MO, Cat. No. 1212/10), solutions were made fresh in sterile saline before use ...
-
bioRxiv - Cell Biology 2023Quote: ... E8 medium was replaced with E6 medium supplemented with 6 uM CHIR99021 (Tocris Bioscience, 4423), 20 ng/mL Bone Morphogenetic Protein 4 (rBMP4 ...
-
bioRxiv - Animal Behavior and Cognition 2023Quote: ... receiving either eglumetad (6 mg/kg, 10.8 mM; also known as LY-354740, Tocris, UK) or saline vehicle injections ...
-
bioRxiv - Neuroscience 2022Quote: ... to block ionotropic gamma-amino-butyric acid receptors (GABAARs) and 10 μM NBQX (1044, Tocris Biosciences) to inhibit α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) ...
-
bioRxiv - Neuroscience 2021Quote: ... 6R)-4-Amino-2-oxabicyclo [3.1.0] hexane-4,6-dicarboxylic acid disodium salt (LY379268, 100 µM, Tocris); calmidazolium chloride (CMZ ...
-
bioRxiv - Genetics 2019Quote: ... As negative controls for pluripotent mESC expression profiles we analyzed retinoic acid (RA; Tocris Biosciences, 0695)–treated mESCs and immortalized mouse embryonic fibroblasts (MEFs) ...
-
bioRxiv - Neuroscience 2023Quote: Susceptibility to seizures induced by the chemoconvulsant KA (kainic acid, Cat #0222, Tocris Bioscience, Minneapolis, MN) was tested in WT ...
-
bioRxiv - Neuroscience 2023Quote: ... and the other half with 10mg/kg of kainic acid (KA) (0222, Tocris, Minneapolis, MN, USA). Behavioral seizure severity was measured using the Racine scale ...
-
bioRxiv - Bioengineering 2023Quote: ... and then to TeSR-E6 supplemented with 0.1 µM TTNPB (a retinoic acid analogue, Tocris, 0761) for 13 days.
-
bioRxiv - Cell Biology 2020Quote: ... cells were stained with 3 µg/mL FM4-64 (Tocris 5118) in BY-2 media then imaged with a 560 nm diode-pumped solid-state laser (Melles Griot ...
-
bioRxiv - Neuroscience 2023Quote: ... the NMDA antagonist AP5 (3 μg/0.5 μl/side; Tocris Bioscience) to the DMS ...
-
bioRxiv - Bioengineering 2023Quote: ... or phosphoinositide 3-kinase (PI3K) (LY 294002, 10 µM, Tocris, UK) for 4 days ...
-
bioRxiv - Cell Biology 2023Quote: ... 0.1 mM 8-Bromoadenosine 3′,5′-cyclic monophosphate sodium salt (Tocris) and 0.1 mM 3-Isobutyl-1-methylxanthine (Sigma-Aldrich) ...
-
bioRxiv - Bioengineering 2023Quote: ... A staining solution was prepared with 3 µM Hoechst 33342 (Tocris), 4 µM calcein-AM (eBioscience) ...
-
bioRxiv - Cell Biology 2023Quote: ... 0.1 mM 8-Bromoadenosine 3′,5′-cyclic monophosphate sodium salt (Tocris) and 0.1 mM 3-Isobutyl-1-methylxanthine (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2019Quote: ... 15 min or 30 min in ACSF mixed with 6 μl of either quinpirole hydrochloride (Tocris; Cat# 1061 ...
-
bioRxiv - Neuroscience 2020Quote: ... JNJ16259685 and 2-Methyl-6-(phenylethynyl)pyridine (MPEP) hydrochloride were purchased from Tocris (Minneapolis MN, USA). (±)-Sulpiride was purchased from MilliporeSigma ...
-
bioRxiv - Bioengineering 2020Quote: Ectoderm differentiation was induced using Essential 6 (E6) medium supplemented with LDN-193189 (100 nM, Tocris) and A83-01 (2 μM ...
-
bioRxiv - Neuroscience 2023Quote: ... Firing was recorded for 6 minutes before and after wash in of muscimol (50 μM, Tocris).
-
bioRxiv - Neuroscience 2023Quote: ... or 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, 10 μM dissolved in H2O; Tocris Bioscience), or tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2023Quote: ... either alone or with 10 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, Tocris). Neurons were fixed with 4% PFA and 4% sucrose in PBS for 10 minutes at room temperature ...
-
bioRxiv - Cell Biology 2024Quote: ... Day 6: The medium was changed with the differentiation medium containing 0.25μM Sant-I (Tocris-#1974), 100ng/mL Noggin (Sino Biological-#10267) ...
-
bioRxiv - Neuroscience 2023Quote: ... Sham mice received a vehicle solution (240 nL of 0.2% ascorbic acid in 0.9% saline; Tocris, USA).
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2021Quote: ... In every animal a volume of 500nl of CNO (3 µM, Tocris) was infused at a rate of 0.5µl/min to target the PAG ...
-
bioRxiv - Genomics 2020Quote: ... ‘‘CBRa’’ medium consists of cSFDM base supplemented with 3 µM CHIR99021 (Tocris), 10 ng/mL recombinant human BMP4 (rhBMP4 ...
-
bioRxiv - Neuroscience 2021Quote: ... we added the CB1 receptor antagonist AM-251 (3 µM; Tocris, UK), or the NO synthase inhibitor L-NAME (200 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... the IS was supplemented with 3 mg/ml biocytin (Tocris, Bristol, UK) or 1.5 mg/ml neurobiotin (Vector Laboratories ...
-
bioRxiv - Genomics 2019Quote: ... and 12 uM of the GSK-3 inhibitor CHIR99021 trihydrochloride (Tocris, 4953). This medium was changed to base heart media 24 hours later (Day 1) ...
-
bioRxiv - Genomics 2021Quote: ... and 12uM of GSK-3 inhibitor CHIR99021 trihydrochloride (4953, Tocris, Bristol, UK). “Heart media” is composed of RPMI (15-040-CM ...
-
bioRxiv - Neuroscience 2023Quote: ... Antagonists included the GABA-A blocker bicuculline methiodide (BCC, 3 μM, Tocris) by itself or ...
-
bioRxiv - Cell Biology 2023Quote: ... Media was then changed to cSFDM with 3 uM CHIR99021 (“C”; Tocris), recombinant human BMP4 (10 ng/ml ...
-
bioRxiv - Bioengineering 2023Quote: ... A83-01 (PeproTech, cat# 9094360 or Tocris, cat# 2939, 0.1-3 µM) and the impedance of monolayers was measured at 10 kHz at every 5 min for 48-96 h ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 μM of 2,3-dihydroxy 6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX, 1044, Tocris Bioscience, UK), 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Neuroscience 2019Quote: ... Cells were split 12–30 h after transfection and plated on glass coverslips in the presence of 50 μM NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; Tocris Bioscience) to avoid AMPAR-mediated toxicity ...
-
bioRxiv - Neuroscience 2022Quote: 5-[2-Chloro-6-(trifluoromethoxy)phenyl]-1,3-dihydro-2H-benzimidazol-2-one (JNJ-5; Tocris, Minneapolis, MN) is a high affinity ...
-
bioRxiv - Neuroscience 2023Quote: ... in the presence of the mGluR5 antagonist 2-methyl-6 (phenylethynyl)-pyridine (MPEP, 25 μM; Tocris Bioscience) in ACSF at 31-33°C as previously (18) ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2024Quote: ... All networks received a 20-min 50 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, in DMSO; Tocris, #0373) treatment on top of that ...
-
bioRxiv - Neuroscience 2024Quote: ... IPSCs were recorded in the presence of 10µM CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Tocris 1045) and 50µM D-AP5 (D-2-amino-5-phosphonovalerate ...
-
bioRxiv - Neuroscience 2020Quote: ... The following agents were used: L-(+)-2-amino-4-phophonobutyric acid (L-AP4; 20μM; Tocris Bioscience, catalog #0103), D-(-)-2-amino-5-phophonopentanoic acid (D-AP5 ...
-
bioRxiv - Developmental Biology 2020Quote: ... and FGF2 (100 ng/ml, R&D) in the presence or absence of retinoic acid (0.1 µM, Tocris). For paraxial mesoderm differentiation ...
-
bioRxiv - Neuroscience 2023Quote: Susceptibility to seizures induced by the chemoconvulsant kainic acid (abbreviated as KA, Cat #0222, Tocris Bioscience, Minneapolis, MN) was assessed in B6 and F1D2 WT and Scn2aE/+mice of both sexes P41-44 days of age ...
-
bioRxiv - Developmental Biology 2021Quote: ... which consists of a N2B27 basal medium supplemented with 3 µM CHIR99021 (Tocris), 1µM PD0325901 (SelleckChem ...
-
bioRxiv - Cancer Biology 2020Quote: ... established tumorspheres were treated with either 0.5 µM or 3 µM CHIR99021 (Tocris) for 5 days ...